Technology | Mammography | November 22, 2016

Device has multiple sensors to measure breast size and tissue stiffness for personalized compression during mammography

Sigmascreening, Sensitive Sigma Paddle, mammography, compression, RSNA 2016

November 22, 2016 — Sigmascreening will introduce the Sensitive Sigma Paddle at the upcoming 102nd Annual Radiological Society of North America (RSNA) meeting, Nov. 27-Dec. 2 in Chicago. The Sensitive Sigma Paddle enables personalized compression for better quality mammograms without unnecessary discomfort for patients.

Each year, an estimated 125 million women throughout the world are imaged using mammography. To get the best image quality during a mammogram with the least amount of radiation, the breast needs to be flattened. This is done by compressing the breast. Under-compression can lead to blurred images, more retakes and a higher average glandular dose (AGD), while over-compression causes discomfort and unnecessary pain for the patient. British research estimates that up to 20 percent of screening-eligible women worldwide decide not to have a mammogram because of the pain. This can decrease the rate of early detection, and delay medical treatment of tumors, thus decreasing women's chances of survival.

The patented Sensitive Sigma Paddle has multiple sensors that measure each breast to optimize compression for each breast. Based on breast size and tissue stiffness, the device calculates the pressure to achieve an optimal compression of 75mmHg and allows for a highly reproducible procedure. Sigmascreening said the Sensitive Sigma Paddle is the first pressure-based compression paddle in the market which provides this pressure information real-time.

Investigational in the United States, the device is CE-marked and is actively being used at breast screening centers and hospitals in England, Germany, Sweden, The Netherlands, Belgium and Switzerland since receiving CE-mark last year.

The relationship between pressure applied during compression of the breast and screening performance was recently investigated in the study “Performance of breast screening and cancer detection depends on mammography compression,” which was presented at the 13th International Workshop of Mammographic Imaging in Malmö, June 2016, and published in Breast Imaging. Researchers computed the compression pressure applied to a series of 113,464 screening mammograms. Screening performance measures were determined for each group. Results demonstrated that compression pressures that are too low lead to a higher recall rate and false positives, and compression pressures that are too high reduce detectability of breast cancer. Cancer detection rate and the positive predictive value were optimal in the middle compression category.

For more information: www.sigmascreening.com


Related Content

News | Computed Tomography (CT)

July 23, 2026 — HOPPR has introduced HOPPR EF Chest CT Narrative Model, a foundation model that processes 3D chest CT ...

Time July 27, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

July 7, 2026 — Imagion Biosystems, Ltd. recently announced it has renewed and extended its collaboration agreement with ...

Time July 07, 2026
arrow
News | Breast Imaging

July 7, 2026 — QT Imaging Holdings, Inc. recently announced it has successfully completed its first routine inspection ...

Time July 07, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Mammography

June 30, 2026 — The Food and Drug Administration has cleared new contrast-enhanced mammography (CEM) and CEM biopsy ...

Time June 30, 2026
arrow
News | Mammography

June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...

Time June 24, 2026
arrow
News | Women's Health

June 2, 2026 — Results of an American College of Radiology-managed retrospective study involving 110,000 women presented ...

Time June 02, 2026
arrow
News

May 21, 2026 – Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 22, 2026
arrow
News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
News | Women's Health

April 16, 2026 – GE HealthCare has expanded its collaboration with DeepHealth, Inc., a wholly-owned subsidiary of RadNet ...

Time April 20, 2026
arrow
Subscribe Now